1. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania. (June 2013) Authors: Vieira da Silva Magalhães, Pedro; Dean, Olivia M; Bush, Ashley I; Copolov, David L; Malhi, Gin S; Kohlmann, Kristy; Jeavons, Susan; Schapkaitz, Ian; Anderson-Hunt, Murray; Berk, Michael Journal: Australian and New Zealand journal of psychiatry Issue: Volume 47:Number 6(2013) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020) Authors: Vivash, Lucy; Malpas, Charles B; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M; Bush, Ashley I; Hovens, Christopher M; Kalincik, T; Darby, David; Velakoulis, Dennis; O'Brien, Terence J Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that are impacted by APOE ε4, sex and age but not pathology: Biomarkers (non‐neuroimaging): Novel biomarkers. (7th December 2020) Authors: Ayton, Scott; Janelidze, Shorena; Roberts, Blaine R.; Palmqvist, Sebastian; Kalinowski, Pawel; Diouf, Ibrahima; Belaidi, Abdel Ali; Stomrud, Erik; Bush, Ashley I; Hansson, Oskar Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 5 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Age-Related Changes in Skeletal Muscle Iron Homeostasis. Issue 1 (23rd July 2022) Authors: Alves, Francesca M; Ayton, Scott; Bush, Ashley I; Lynch, Gordon S; Koopman, René Editors: de Cabo, Rafael Journal: Journals of gerontology Issue: Volume 78:Issue 1(2023) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Issue 11 (25th January 2022) Authors: Wang, Tingting; Huynh, Kevin; Giles, Corey; Mellett, Natalie A; Duong, Thy; Nguyen, Anh; Lim, Wei Ling Florence; Smith, Alex AT; Olshansky, Gavriel; Cadby, Gemma; Hung, Joseph; Hui, Jennie; Beilby, John; Watts, Gerald F; Chatterjee, Pratishtha; Martins, Ian; Laws, Simon M; Bush, Ashley I; Rowe, C... Journal: Alzheimer's & dementia Issue: Volume 18:Issue 11(2022) Page Start: 2151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗